ARTICLE | Company News
Dendreon, Kirin deal
May 10, 1999 7:00 AM UTC
The partners expanded their 1998 license agreement under which Kirin's Pharmaceutical Division and Dendreon are developing dendritic cell-based immunotherapies to treat cancer (see BioCentury, Dec. 14...